Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

Ítems similars

• Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
  per: Kovatchev, Boris, et al.
  Publicat: (2020)
• Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial
  per: Bolli, Geremia B., et al.
  Publicat: (2021)
• In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
  per: Schiavon, Michele, et al.
  Publicat: (2020)
• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  per: Steinstraesser, A, et al.
  Publicat: (2014)
• Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
  per: Vargas-Uricoechea, Hernando
  Publicat: (2018)